F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection.
Inflammation forms an important core of the aetiopathogenic process involved in many diseases affecting the heart and the blood vessels. These diseases include infections as well as inflammatory non-infectious cardiovascular conditions. The common feature of this is invasion of the heart or blood vessel by inflammatory cells. F-18 2-fluoro 2-deoxy-D glucose (FDG) is an analogue of glucose and like glucose it is taken up by activated inflammatory cells that accumulate at the site of infection. This has formed the basis of the use of F-18 FDG PET/CT in the non-invasive evaluation of human inflammatory diseases.



This review is based on the published academic articles as well as our clinical experience.



F-18 FDG PET/CT is a useful imaging modality in the evaluation of cardiovascular inflammatory disorders. Accumulation and distribution of F-18 FDG at the site of inflammation/infection corresponds to severity of the inflammation/infection and extent of involvement.



Most studies evaluating utility of F-18 FDG PET/CT in imaging cardiovascular inflammation are small observational studies hence are potentially prone to bias.



Being a hybrid metabolic and morphologic imaging technique, F-18 FDG PET/CT offers combined advantage of complementary anatomic and metabolic information in disease process. This makes it a useful modality in the diagnosis, determination of extent of disease, prognostication as well as treatment monitoring.



Larger prospective studies are needed to validate the superiority of F-18 FDG PET/CT imaging over conventional anatomic imaging modalities.
Department of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria 0001, South Africa.
Ismaheel
I
Lawal
Department of Nuclear Medicine, Steve Biko Academic Hospital, University of Pretoria, Private Bag X169, Pretoria 0001, South Africa mike.sathekge@up.ac.za.
Mike
M
Sathekge
D009202:Cardiomyopathies / Q000000981:diagnostic imaging* / Q000473:pathology; D004696:Endocarditis / Q000000981:diagnostic imaging* / Q000473:pathology; D019317:Evidence-Based Medicine; D019788:Fluorodeoxyglucose F18 / Q000627:therapeutic use*; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007249:Inflammation / Q000000981:diagnostic imaging*; D010493:Pericarditis / Q000000981:diagnostic imaging* / Q000473:pathology; D000072078:Positron Emission Tomography Computed Tomography; D017410:Practice Guidelines as Topic; D019275:Radiopharmaceuticals / Q000627:therapeutic use*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
FDG PET/CT; cardiovascular; inflammation